These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9243932)

  • 21. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice.
    LaRue B; Hogg E; Sagare A; Jovanovic S; Maness L; Maurer C; Deane R; Zlokovic BV
    J Neurosci Methods; 2004 Sep; 138(1-2):233-42. PubMed ID: 15325132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer's disease pathology.
    Zlokovic B
    Neurobiol Dis; 1997; 4(1):23-6. PubMed ID: 9258908
    [No Abstract]   [Full Text] [Related]  

  • 23. Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study.
    Cheng H; Xu J; McKeel DW; Han X
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):809-18. PubMed ID: 14528918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Messenger RNA and protein expression analysis of voltage-gated potassium channels in the brain of Abeta(25-35)-treated rats.
    Pan Y; Xu X; Tong X; Wang X
    J Neurosci Res; 2004 Jul; 77(1):94-9. PubMed ID: 15197742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
    Montalto MC; Farrar G; Hehir CT
    Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell cycle-driven neuronal apoptosis specifically linked to amyloid peptide Abeta1-42 exposure is not exacerbated in a mouse model of presenilin-1 familial Alzheimer's disease.
    Malik B; Currais A; Soriano S
    J Neurochem; 2008 Jul; 106(2):912-6. PubMed ID: 18466334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental model of neuropathological changes characteristic for Alzheimer's disease.
    Pluta R
    Folia Neuropathol; 1997; 35(2):94-8. PubMed ID: 9377082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of ischemic blood-brain barrier on amyloid plaques development in Alzheimer's disease brain.
    Pluta R
    Curr Neurovasc Res; 2007 May; 4(2):121-9. PubMed ID: 17504210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transport of human beta-amyloid peptide through the rat blood-brain barrier after global cerebral ischemia.
    Pluta R; Misicka A; Januszewski S; Barcikowska M; Lipkowski AW
    Acta Neurochir Suppl; 1997; 70():247-9. PubMed ID: 9416336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neuropathology of Alzheimer disease. Proceedings of a workshop presented by the John Douglas French Foundation for Alzheimer's Disease. November 6-7, 1986. Abstracts.
    Bull Clin Neurosci; 1987; 52():1-33. PubMed ID: 3509357
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neuronal cell death].
    Wakutani Y; Urakami K
    Nihon Rinsho; 2011 Oct; 69 Suppl 8():200-3. PubMed ID: 22787781
    [No Abstract]   [Full Text] [Related]  

  • 33. Cerebral microischemia as a potential precipitant of the neurodegenerative cascade of Alzheimer's disease.
    Richardson JS
    Ann N Y Acad Sci; 1997 Sep; 826():437-9. PubMed ID: 9329719
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood-Brain Barrier Leakage in Early Alzheimer Disease.
    Lecler A; Fournier L; Diard-Detoeuf C; Balvay D
    Radiology; 2017 Mar; 282(3):923-925. PubMed ID: 28218884
    [No Abstract]   [Full Text] [Related]  

  • 35. Future directions in animal models of Alzheimer's disease.
    Beckman D; Baxter MG; Morrison JH
    J Neurosci Res; 2018 Dec; 96(12):1829-1830. PubMed ID: 30204256
    [No Abstract]   [Full Text] [Related]  

  • 36. A promising rat model of Alzheimer's disease-like neuropathology.
    Pluta R; Misicka A; Barcikowska M; Januszewski S; Lipkowski AW
    Folia Morphol (Warsz); 1996; 55(4):417-9. PubMed ID: 9243932
    [No Abstract]   [Full Text] [Related]  

  • 37. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
    Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
    Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detecting bioactive amyloid beta peptide species in Alzheimer's disease.
    Liu Y; Dargusch R; Banh C; Miller CA; Schubert D
    J Neurochem; 2004 Nov; 91(3):648-56. PubMed ID: 15485495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
    Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM
    Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.